Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

Delayed Quote. Delayed  - 05/26 09:59:59 pm
8.03 USD   -1.47%
05/24 ARIAD PHARMACEU : Company Update Ariad Pharmaceuticals, Inc. Announc..
05/24 ARIAD PHARMACEU : Announces Appointment of Jennifer L. Herron as Chi..
05/19 ARIAD PHARMACEU : Announces Pricing and Reimbursement for Iclusig in..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2016 05/23/2016 05/24/2016 05/25/2016 05/26/2016 Date
7.75(c) 8.08(c) 7.97(c) 8.15(c) 8.04(c) Last
5 019 766 9 018 583 7 305 398 3 154 427 1 897 241 Volume
+1.17% +4.26% -1.36% +2.26% -1.35% Change
More quotes
Financials ($)
Sales 2016 217 M
EBIT 2016 -96,5 M
Net income 2016 -108 M
Debt 2016 224 M
Yield 2016 -
Sales 2017 258 M
EBIT 2017 -79,0 M
Net income 2017 -94,6 M
Debt 2017 240 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 8,19x
EV / Sales 2017 6,97x
Capitalization 1 559 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
Sector
Biotechnology & Medical Research
Calendar
06/04 | 03:00pmPresentation
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
05/26 ARIAD PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financial..
05/24 ARIAD PHARMACEUTICALS : Company Update Ariad Pharmaceuticals, Inc. Announces App..
05/24 ARIAD PHARMACEUTICALS : Announces Appointment of Jennifer L. Herron as Chief Com..
05/20 ARIAD PHARMACEUTICALS INC : Change in Directors or Principal Officers, Amendment..
05/19 ARIAD PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (for..
05/19 ARIAD PHARMACEUTICALS : Reports First Quarter 2016 Financial Results and Progres..
05/19 ARIAD PHARMACEUTICALS : Announces Pricing and Reimbursement for Iclusig in Franc..
05/18 ARIAD PHARMACEUTICALS : Announces Data Presentations at the 2016 ASCO Annual Mee..
More news
Sector news : Bio Therapeutic Drugs
05/26 ALDER BIOPHARMACEUTICALS : Continues to Strengthen and Expand Leadership Team to..
05/26DJIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
05/26 REGENERON PHARMACEUTICALS : Selected by Society for Science & the Public as New ..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/24 New commercial chief at ARIAD Pharma
05/19 Iclusig reimbursement finalized in France; ARIAD to recognize $25M in sales i..
05/11 PDL Bio and ARIAD Pharma amend synthetic royalty agreement after Incyte deal
05/10 ARIAD Pharmaceuticals' (ARIA) CEO Paris Panayiotopoulos on Q1 2016 Results - ..
05/10 SEEKING ALPHA'S MARKET CHALLENGE : Looking Long Term At Healthcare, Biotech
Comments 
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions